Abstract:AIM: To investigate synergism of inhibition of telomerase activity and proliferation of human colon cancer cells by combination of telomerase antisense oligonucleotides (ASODNs) simultaneously targeting human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT) in vitro. METHODS: ASODN of hTR and ASODN of hTERT were transfected into human colon cancer SW480 cells by liposomal transfection reagents. Telomerase activity of SW480 cells was examined using telomeric repeat amplification protocol (TRAP)-enzyme-linked immunosorbent assay (PCR-ELISA). Proliferation activity of SW480 cells was tested by methyl thiazolyl tetrazolium assay. Apoptosis and cell cycle were analyzed by flow cytometry. RESULTS: The telomerase activity and cell survival rate in SW480 cells transfected with 0.2 mu mol/L of ASODN of hTR or ASODN of hTERT for 24-72 h were significantly decreased in a time-dependent manner compared with those after treatment with sense oligonucleotides and untreated (telomerase activity: 24 h, 73%, 74% vs 99%, 98%; 48 h, 61%, 55% vs 98%, 99%; 72 h, 41%, 37% vs 99%, 97%; P<0.01; cell survival rate: 24 h, 88%, 86% vs 94%, 98%; 48 h, 49%, 47% vs 94%, 97%; 72 h, 44%, 42% vs 92%, 96%; P<0.01). Moreover, the telomerase activity and the cell survival rate in SW480 cells treated by the combination of telomerase anti-hTR and anti-hTERT were more significantly suppressed than single anti-hTR or anti-hTERT (telomerase activity: 24 h, 59% vs 73%, 74%; 48 h, 43% vs 61%, 55%; 72 h, 18% vs 41%, 37%; P<0.01; cell survival rate: 24 h, 64% vs 88%, 86%; 48 h, 37% vs 49%, 47%; 72 h, 25% vs 44%, 42%; P<0.01). Meanwhile, the apoptosis rates in the combination group were markedly increased compared with those in the single group (24 h, 18.0% vs 7.2%, 7.4%; 48 h, 23.0% vs 13.0%, 14.0%; 72 h, 28.6% vs 13.2%, 13.75; P<0.01). Cells in combination group were arrested at G(0)/G(1) phase. CONCLUSION: Telomerase anti-hRT and anti-hTERT suppress telomerase activity, and inhibit growth of human colon cancer cells probably via induction of apoptosis and retardation of cell cycle. Additionally, combined use of telomerase ASODNs targeting both hTR and hTERT yields synergistic action selective for human colon cancer. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.

The antitumor effect and mechanism of antisense oligonucleotide against hTR with all-trans retinoic acid on oral squamous cell carcinoma

Antisense Oligonucleotides and All-Trans Retinoic Acid Have a Synergistic Anti-Tumor Effect on Oral Squamous Cell Carcinoma

Synergistic Down-Regulation of Telomerase by All-Trans Retinoic Acid and Antisense Oligonucleotide in Oral Squamous Cell Carcinoma Cell Line (Tca8113)

Effect of Combination of Curcumin and GLUT-1 AS-ODN on Radiosensitivity of Laryngeal Carcinoma Through Regulating Autophagy

Antisense Oligonucleotides Targeting Human Telomerase Mrna Increases the Radiosensitivity of Nasopharyngeal Carcinoma Cells

Inhibitory Effect of Antisense Oligodeoxynucleotides Against Htert on Nude Mice Transplantation Tumor of Human Tongue Tca8113 Cancer Cell

Can Inhibition of Telomerase Increase Pancreatic Cancer Cell's Susceptibility to Chemotherapeutic Reagents?

Efficient inhibition of human telomerase activity by antisense oligonucleotides sensitizes cancer cells to radiotherapy

Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line

Stable Expression of Antisense Htr Inhibits in Vitro Pancreatic Cancer Cell Growth.

Antitumor Efficacy of Human Telomerase Reverse Transcriptase Gene Antisense Oligonucleotide in Pancreatic Cancer Cells.

Antisense Inhibition of ATM Gene Enhances the Radiosensitivity of Head and Neck Squamous Cell Carcinoma in Mice

Trichostatin A Combined with All-trans Retinoic Acid Induce Apoptosis in Human Ovarian Cancer Cell Line SKOV-3

Synergistic effect of trichostatina A combined with all-trans retinoic acid on induction of apoptosis of cervical cancer SiHa cells

Telomerase Reverse Transcriptase Interference Synergistically Promotes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Oral Squamous Cell Carcinoma Apoptosis And Suppresses Proliferation In Vitro And In Vivo

Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.

[Inhibition of Telomerase Activity and Induction of Apoptosis in Lung Cancer Cell by Human Telomerase Reverse Transcriptase Gene Antisense Oligodeoxynucleotide].

Study on the Correlation of Telomerase Activity and Differentiation of Cultured Osteosarcoma Cells

[Inhibition Effects of C-Erbb-2 and C-Raf-1 Antisense Oligodeoxynucleotides Combined Transfection on the Human Ovarian Carcinoma Transplanted Subcutaneously in Nude Mice].

[Telomerase RNA Antisense Oligonucleotides Inhibit Growth of Human Choriocarcinoma Xenograft in Nude Mice].

[Inhibition Effects of Phosphorothioate-Modified Antisense Htr on the Telomerase Activity and the Growth of P3 Cells Derived from Pancreatic Cancer in Culture].